Long-term insulin treatment restores cardioprotection induced by sufentanil postconditioning in diabetic rat heart

Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial

(2014) Hertzel C Gerstein et al.   LANCET

Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats

(2013) Haobo Li et al.   Cardiovascular Diabetology

Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism

(2013) Charissa E van den Brom et al.   Cardiovascular Diabetology

Diabetes mellitus abrogates the cardioprotection of sufentanil against ischaemia/reperfusion injury by altering glycogen synthase kinase-3β

(2012) Q. L. CHEN et al.   ACTA ANAESTHESIOLOGICA SCANDINAVICA

Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study

(2012) Richard Engbersen et al.   Cardiovascular Diabetology

High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels

(2012) Taiga Ichinomiya et al.   Cardiovascular Diabetology

Cardioprotective Effects of Insulin

(2012) Keng Wooi Ng et al.   CIRCULATION

Sufentanil limits the myocardial infarct size by preservation of the phosphorylated connexin 43

(2012) Yun Wu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Ischemic Postconditioning Mediates Cardioprotection Via PI3K/GSK-3β/β-Catenin Signaling Pathway in Ischemic Rat Myocardium

(2012) Qiao-ling Wu et al.   SHOCK

Diabetes Blockade of Sevoflurane Postconditioning Is Not Restored by Insulin in the Rat Heart

(2011) Benjamin Drenger et al.   ANESTHESIOLOGY

Phosphorylation of GSK-3β Mediates Intralipid-induced Cardioprotection against Ischemia/Reperfusion Injury

(2011) Siamak Rahman et al.   ANESTHESIOLOGY

Early intensive insulin therapy attenuates the p38 pathway in the renal cortex and indices of nephropathy in diabetic rats

(2011) Donghong Fang et al.   ENDOCRINE JOURNAL

Diabetic Inhibition of Preconditioning- and Postconditioning-Mediated Myocardial Protection against Ischemia/Reperfusion Injury

(2011) Xia Yin et al.   Experimental Diabetes Research

Cardioprotection with Postconditioning: Loss of Efficacy in Murine Models of Type-2 and Type-1 Diabetes

(2010) Karin Przyklenk et al.   ANTIOXIDANTS & REDOX SIGNALING

Metformin Use and Mortality in Ambulatory Patients With Diabetes and Heart Failure

(2010) David Aguilar et al.   Circulation-Heart Failure

GSK-3β, a Therapeutic Target for Cardiomyocyte Protection

(2009) Tetsuji Miura et al.   CIRCULATION JOURNAL

Role of Glycogen Synthase Kinase-3β in Cardioprotection

(2009) Magdalena Juhaszova et al.   CIRCULATION RESEARCH

Endoplasmic Reticulum Stress in Diabetic Hearts Abolishes Erythropoietin-Induced Myocardial Protection by Impairment of Phospho–Glycogen Synthase Kinase-3β–Mediated Suppression of Mitochondrial Permeability Transition

(2009) Takayuki Miki et al.   DIABETES

Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival

(2009) Hyun Soo Kim et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: Role of GSK-3β in Myocardial Protection Against Ischemia/Reperfusion Injury

(2009) Tetsuji Miura et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo : cardioprotection can be restored by blocking the mitochondrial permeability transition pore

(2008) R. Huhn et al.   BRITISH JOURNAL OF ANAESTHESIA

Ischemic Preconditioning: From Molecular Mechanisms to Therapeutic Opportunities

(2007) Hajime Otani   ANTIOXIDANTS & REDOX SIGNALING